Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture

Journal of Nutritional Biochemistry

Volumn 22, Issue 10, 2011, Pages 945-955

  Hoefig, Carolin S ^a   Renko, Kostja ^a   Köhrle, Josef ^a   Birringer, Marc ^b   Schomburg, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

HepG2; Micronutrient; Selenium; Selenoprotein P; Toxicity; Trace element

Indexed keywords

EBSELEN; GLUTATHIONE DERIVATIVE; GLUTATHIONE PEROXIDASE 1; METHYLSELENINIC ACID; SELENATE; SELENITE; SELENIUM DERIVATIVE; SELENOCYSTINE; SELENODIGLUTATHIONE; SELENOMETHIONINE; SELENOMETHYLSELENOCYSTEINE; SELENOPROTEIN; SELENOPROTEIN P; SODIUM SELENITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CULTURE; MOUSE; NONHUMAN; NUTRITIONAL VALUE; PROTEIN EXPRESSION; PROTEIN SECRETION; STEREOISOMERISM; TOXICITY TESTING;

ANIMALS; CYSTINE; DIETARY SUPPLEMENTS; GLUTATHIONE; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, KNOCKOUT; NUTRITIVE VALUE; ORGANOSELENIUM COMPOUNDS; SELENOPROTEIN P; SODIUM SELENITE;

MURINAE;

EID: 79957525768     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.006     Document Type: Article

References (86)

1. Hatfield D.L., Gladyshev V.N. How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002, 22:3565-3576.
2. Birringer M., Pilawa S., Flohé L. Trends in selenium biochemistry. Nat Prod Rep 2002, 19:693-718.
3. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007, 9:775-806.
4. Burk R.F., Hill K.E. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005, 25:215-235.
5. Barceloux D.G. Selenium. J Toxicol Clin Toxicol 1999, 37:145-172.
6. Beckett G.J., Arthur J.R. Selenium and endocrine systems. J Endocrinol 2005, 184:455-465.
7. Combs G.F. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 2005, 135:343-347.
8. Gromadzinska J., Reszka E., Bruzelius K., Wasowicz W., Akesson B. Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr 2008, 47:29-50.
9. Schomburg L., Köhrle J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 2008, 52:1235-1246.
10. Rayman M.P. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 2009, 1790:1533-1540.
11. Behne D., Hilmert H., Scheid S., Gessner H., Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim Biophys Acta 1988, 966:12-21.
12. Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., et al. Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem J 1995, 311(Pt 2):425-430.
13. Flohé L. Selenium in mammalian spermiogenesis. Biol Chem 2007, 388:987-995.
14. Schomburg L., Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta 2009, 1790:1453-1462.
15. Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., et al. Selenoprotein gene expression during selenium-repletion of selenium-deficient rats. Biol Trace Elem Res 1996, 51:211-223.
16. Lei X.G., Evenson J.K., Thompson K.M., Sunde R.A. Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium. J Nutr 1995, 125:1438-1446.
17. Weitzel F., Ursini F., Wendel A. Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. Biochim Biophys Acta 1990, 1036:88-94.
18. Budiman M.E., Bubenik J.L., Miniard A.C., Middleton L.M., Gerber C.A., Cash A., et al. Eukaryotic initiation factor 4a3 is a selenium-regulated RNA-binding protein that selectively inhibits selenocysteine incorporation. Mol Cell 2009, 35:479-489.
19. Hill K.E., Zhou J., McMahan W.J., Motley A.K., Atkins J.F., Gesteland R.F., et al. Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 2003, 278:13640-13646.
20. Schomburg L., Schweizer U., Holtmann B., Flohé L., Sendtner M., Köhrle J. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 2003, 370:397-402.
21. Renko K., Werner M., Renner-Muller I., Cooper T.G., Yeung C.H., Hollenbach B., et al. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem J 2008, 409:741-749.
22. Schomburg L., Schweizer U., Köhrle J. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 2004, 61:1988-1995.
23. Olson G.E., Whitin J.C., Hill K.E., Winfrey V.P., Motley A.K., Austin L.M., et al. Extracellular glutathione peroxidase (Gpx3) binds specifically to basement membranes of mouse renal cortex tubule cells. Am J Physiol Renal Physiol 2009, 298(5):F1244-F1253.
24. Olson G.E., Winfrey V.P., Hill K.E., Burk R.F. Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J Biol Chem 2008, 283:6854-6860.
25. Wu X., Huang K., Wei C., Chen F., Pan C. Regulation of cellular glutathione peroxidase by different forms and concentrations of selenium in primary cultured bovine hepatocytes. J Nutr Biochem 2010, 21(2):153-161.
26. Schomburg L., Dumitrescu A.M., Liao X.H., Bin-Abbas B., Hoeflich J., Köhrle J., et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009, 19:277-281.
27. Sahin N., Onderci M., Sahin K., Kucuk O. Supplementation with organic or inorganic selenium in heat-distressed quail. Biol Trace Elem Res 2008, 122:229-237.
28. Juniper D.T., Phipps R.H., Ramos-Morales E., Bertin G. Effect of dietary supplementation with selenium-enriched yeast or sodium selenite on selenium tissue distribution and meat quality in beef cattle. J Anim Sci 2008, 86:3100-3109.
29. Burk R.F., Norsworthy B.K., Hill K.E., Motley A.K., Byrne D.W. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006, 15:804-810.
30. Schrauzer G.N. Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr 2001, 20:1-4.
31. Burk R.F., Hill K.E., Motley A.K. Plasma selenium in specific and non-specific forms. Biofactors 2001, 14:107-114.
32. Schrauzer G.N. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 2003, 47:73-112.
33. Carlson B.A., Novoselov S.V., Kumaraswamy E., Lee B.J., Anver M.R., Gladyshev V.N., et al. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 2004, 279:8011-8017.
34. Burk R.F., Hill K.E. Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 2009, 1790(11):1441-1447.
35. Sheehan T.M., Gao M. Simplified fluorometric assay of total selenium in plasma and urine. Clin Chem 1990, 36:2124-2126.
36. Koh T.S., Benson T.H. Critical re-appraisal of fluorometric method for determination of selenium in biological materials. J Assoc Off Anal Chem 1983, 66:918-926.
37. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986, 89:271-277.
38. Hollenbach B., Morgenthaler N.G., Struck J., Alonso C., Bergmann A., Köhrle J., et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008, 22:24-32.
39. Dumitrescu A.M., Liao X.H., Abdullah M.S., Lado-Abeal J., Majed F.A., Moeller L.C., et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005, 37:1247-1252.
40. Schweizer U., Michaelis M., Köhrle J., Schomburg L. Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem J 2004, 378:21-26.
41. Flohé L., Günzler W.A. Assays of glutathione peroxidase. Methods Enzymol 1984, 105:114-121.
42. Hill K.E., Lyons P.R., Burk R.F. Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency. Biochem Biophys Res Commun 1992, 185:260-263.
43. Hill K.E., Chittum H.S., Lyons P.R., Boeglin M.E., Burk R.F. Effect of selenium on selenoprotein P expression in cultured liver cells. Biochim Biophys Acta 1996, 1313:29-34.
44. Ip C., Birringer M., Block E., Kotrebai M., Tyson J.F., Uden P.C., et al. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 2000, 48:2062-2070.
45. Lanfear J., Fleming J., Wu L., Webster G., Harrison P.R. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium?. Carcinogenesis 1994, 15:1387-1392.
46. Dong Y., Ganther H.E., Stewart C., Ip C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res 2002, 62:708-714.
47. Sinha R., El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr Cancer Drug Targets 2004, 4:13-28.
48. Rooprai H.K., Kyriazis I., Nuttall R.K., Edwards D.R., Zicha D., Aubyn D., et al. Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol 2007, 30:1263-1271.
49. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:233-241.
50. Combs G.F. Selenium in global food systems. Br J Nutr 2001, 85:517-547.
51. Stranges S., Marshall J.R., Natarajan R., Donahue R.P., Trevisan M., Combs G.F., et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147:217-223.
52. Bleys J., Navas-Acien A., Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007, 30:829-834.
53. Stranges S., Laclaustra M., Ji C., Cappuccio F.P., Navas-Acien A., Ordovas J.M., et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 2010, 140:81-87.
54. MacFarquhar J.K., Broussard D.L., Melstrom P., Hutchinson R., Wolkin A., Martin C., et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med 2010, 170:256-261.
55. Ip C., Hayes C., Budnick R.M., Ganther H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res 1991, 51:595-600.
56. Xia Y., Hill K.E., Byrne D.W., Xu J., Burk R.F. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005, 81:829-834.
57. 82Se-selenite. Toxicol Appl Pharmacol 2006, 217:185-195.
58. Burk R.F., Early D.S., Hill K.E., Palmer I.S., Boeglin M.E. Plasma selenium in patients with cirrhosis. Hepatology 1998, 27:794-798.
59. Navarro-Alarcon M., Lopez-Ga de la Serrana H., Perez-Valero V., Lopez-Martinez M.C. Selenium concentrations in serum of individuals with liver diseases (cirrhosis or hepatitis): relationship with some nutritional and biochemical markers. Sci Total Environ 2002, 291:135-141.
60. 77Se-selenomethionine by absolute labeling and speciation. Toxicol Appl Pharmacol 2006, 217:43-50.
61. Schweizer U., Streckfuss F., Pelt P., Carlson B.A., Hatfield D.L., Köhrle J., et al. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J 2005, 386:221-226.
62. Ip C., Dong Y., Ganther H.E. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002, 21:281-289.
63. Irons R., Carlson B.A., Hatfield D.L., Davis C.D. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 2006, 136:1311-1317.
64. Novoselov S.V., Calvisi D.F., Labunskyy V.M., Factor V.M., Carlson B.A., Fomenko D.E., et al. Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene 2005, 24:8003-8011.
65. Alwahaibi N., Mohamed J., Alhamadani A. Supplementation of selenium reduces chemical hepatocarcinogenesis in male Sprague-Dawley rats. J Trace Elem Med Biol 2010, 24:119-123.
66. Mahn A.V., Toledo H.M., Ruz M. Dietary supplementation with selenomethylselenocysteine produces a differential proteomic response. J Nutr Biochem 2009, 20:791-799.
67. Lu J., Berndt C., Holmgren A. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase. Biochim Biophys Acta 2009, 1790:1513-1519.
68. Parnham M.J. Biological activities and clinical potential of ebselen. Adv Exp Med Biol 1990, 264:193-197.
69. Schewe T. Molecular actions of ebselen-an antiinflammatory antioxidant. Gen Pharmacol 1995, 26:1153-1169.
70. Van Dael P., Davidsson L., Munoz-Box R., Fay L.B., Barclay D. Selenium absorption and retention from a selenite- or selenate-fortified milk-based formula in men measured by a stable-isotope technique. Br J Nutr 2001, 85:157-163.
71. Temple K.A., Smith A.M., Cockram D.B. Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. J Ren Nutr 2000, 10:16-23.
72. Finley J.W. The retention and distribution by healthy young men of stable isotopes of selenium consumed as selenite, selenate or hydroponically-grown broccoli are dependent on the isotopic form. J Nutr 1999, 129:865-871.
73. Persson-Moschos M., Alfthan G., Akesson B., Plasma selenoprotein P. Levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 1998, 52:363-367.
74. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35:118-126.
75. Schomburg L. A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis. Shock 2010, 33:554-555.
76. Weiller M., Latta M., Kresse M., Lucas R., Wendel A. Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes. Toxicology 2004, 201:21-30.
77. Olm E., Fernandes A.P., Hebert C., Rundlof A.K., Larsen E.H., Danielsson O., et al. Extracellular thiol-assisted selenium uptake dependent on the x(c)-cystine transporter explains the cancer-specific cytotoxicity of selenite. Proc Natl Acad Sci U S A 2009, 106:11400-11405.
78. Danielsson B.R., Danielson M., Khayat A., Wide M. Comparative embryotoxicity of selenite and selenate: uptake in murine embryonal and fetal tissues and effects on blastocysts and embryonic cells in vitro. Toxicology 1990, 63:123-136.
79. Rebsch C.M., Penna F.J., Copeland P.R. Selenoprotein expression is regulated at multiple levels in prostate cells. Cell Res 2006, 16:940-948.
80. Misra S., Niyogi S. Selenite causes cytotoxicity in rainbow trout (Oncorhynchus mykiss) hepatocytes by inducing oxidative stress. Toxicol In Vitro 2009, 23:1249-1258.
81. Cuello S., Ramos S., Mateos R., Martin M.A., Madrid Y., Camara C., et al. Selenium methylselenocysteine protects human hepatoma HepG2 cells against oxidative stress induced by tert-butyl hydroperoxide. Anal Bioanal Chem 2007, 389:2167-2178.
82. Zeng H., Wu M., Botnen J.H. Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J Nutr 2009, 139:1613-1618.
83. Wu M., Kang M.M., Schoene N.W., Cheng W.H. Selenium compounds activate early barriers of tumorigenesis. J Biol Chem 2010, 285:12055-12062.
84. Rayman M.P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005, 64:527-542.
85. Gärtner R., Gasnier B.C., Dietrich J.W., Krebs B., Angstwurm M.W. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002, 87:1687-1691.
86. Muecke R., Schomburg L., Glatzel M., Berndt-Skorka R., Baaske D., Reichl B., et al. Multicenter, Phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010, 78(3):828-835.